Back to searchBackground Papers2
Result Papers0
Derived Papers0
Unknown Papers5
Benefits of Switching Antidepressants Following Early Nonresponse
NCT00519012
PHASE4INTERVENTIONAL
Oizumi Hospital
200 participants
Started 2007-08 · Completed 2010-12
Status: Unknown (as of 12-23-2025)
Conditions
Depression
Linked Papers (from SciSciNet-V2)
Total Papers6
Background
1Result
0Derived
0Unknown
5Total Citations Per Year
Brief Summary
Introduction and Purpose: Most of the guidelines for the treatment of major depression recommend the use of antidepressants for 4 to 8 weeks. On the other hand, it has been recently reported that they start to show their antidepressant efficacy within a couple of weeks (1,2), contrary to the conventional theory. In addition, a good response (i.e. a 20% reduction in the Montgomery-Åsberg Depression Rating Scale \[MADRS\]) at week 2 is proposed to be a predictor of subsequent remission at week 6 (3,4), while nonresponse at week 2 could predict unfavourable outcome at week 8 (5). Furthermore, early worsening is suggested to be related to a low rate of remission at weeks 8 and 12(6).
Sort by:
Background Papers2
Result Papers0
No result papers linked
Derived Papers0
No derived papers linked
Unknown Papers5
Onset and Early Behavioral Effects of Pharmacologically Different Antidepressants and Placebo in Depression
2003
241 citations
Early nonresponse to fluoxetine as a predictor of poor 8-week outcome
1995
182 citations
Early Improvement Under Mirtazapine and Paroxetine Predicts Later Stable Response and Remission With High Sensitivity in Patients With Major Depression
2003
176 citations
A Meta-Analysis of Early Sustained Response Rates Between Antidepressants and Placebo for the Treatment of Major Depressive Disorder
2006
113 citations
Early Symptomatic Worsening During Treatment With Fluoxetine in Major Depressive Disorder
2007
19 citations